Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

262 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
STX6 rs1411478 is not associated with increased risk of Parkinson's disease.
Trinh J, Vilariño-Güell C, Donald A, Shah B, Yu I, Szu-Tu C, Aasly JO, Wu RM, Hentati F, Rajput AH, Rajput A, Farrer MJ. Trinh J, et al. Among authors: aasly jo. Parkinsonism Relat Disord. 2013 May;19(5):563-5. doi: 10.1016/j.parkreldis.2013.01.019. Epub 2013 Feb 14. Parkinsonism Relat Disord. 2013. PMID: 23415606
Parkinsonism, FXTAS, and FMR1 premutations.
Toft M, Aasly J, Bisceglio G, Adler CH, Uitti RJ, Krygowska-Wajs A, Lynch T, Wszolek ZK, Farrer MJ. Toft M, et al. Mov Disord. 2005 Feb;20(2):230-3. doi: 10.1002/mds.20297. Mov Disord. 2005. PMID: 15390127
LRRK2 mutations are not common in Alzheimer's disease.
Toft M, Sando SB, Melquist S, Ross OA, White LR, Aasly JO, Farrer MJ. Toft M, et al. Among authors: aasly jo. Mech Ageing Dev. 2005 Nov;126(11):1201-5. doi: 10.1016/j.mad.2005.06.010. Mech Ageing Dev. 2005. PMID: 16087219
Lrrk2 pathogenic substitutions in Parkinson's disease.
Mata IF, Kachergus JM, Taylor JP, Lincoln S, Aasly J, Lynch T, Hulihan MM, Cobb SA, Wu RM, Lu CS, Lahoz C, Wszolek ZK, Farrer MJ. Mata IF, et al. Neurogenetics. 2005 Dec;6(4):171-7. doi: 10.1007/s10048-005-0005-1. Epub 2005 Sep 17. Neurogenetics. 2005. PMID: 16172858
Genomewide association, Parkinson disease, and PARK10.
Farrer MJ, Haugarvoll K, Ross OA, Stone JT, Milkovic NM, Cobb SA, Whittle AJ, Lincoln SJ, Hulihan MM, Heckman MG, White LR, Aasly JO, Gibson JM, Gosal D, Lynch T, Wszolek ZK, Uitti RJ, Toft M. Farrer MJ, et al. Among authors: aasly jo. Am J Hum Genet. 2006 Jun;78(6):1084-8; author reply 1092-4. doi: 10.1086/504728. Am J Hum Genet. 2006. PMID: 16685661 Free PMC article. No abstract available.
Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease.
Maraganore DM, de Andrade M, Elbaz A, Farrer MJ, Ioannidis JP, Krüger R, Rocca WA, Schneider NK, Lesnick TG, Lincoln SJ, Hulihan MM, Aasly JO, Ashizawa T, Chartier-Harlin MC, Checkoway H, Ferrarese C, Hadjigeorgiou G, Hattori N, Kawakami H, Lambert JC, Lynch T, Mellick GD, Papapetropoulos S, Parsian A, Quattrone A, Riess O, Tan EK, Van Broeckhoven C; Genetic Epidemiology of Parkinson's Disease (GEO-PD) Consortium. Maraganore DM, et al. Among authors: aasly jo. JAMA. 2006 Aug 9;296(6):661-70. doi: 10.1001/jama.296.6.661. JAMA. 2006. PMID: 16896109
PINK1 mutation heterozygosity and the risk of Parkinson's disease.
Toft M, Myhre R, Pielsticker L, White LR, Aasly JO, Farrer MJ. Toft M, et al. Among authors: aasly jo. J Neurol Neurosurg Psychiatry. 2007 Jan;78(1):82-4. doi: 10.1136/jnnp.2006.097840. J Neurol Neurosurg Psychiatry. 2007. PMID: 17172567 Free PMC article.
262 results